support@activebiopharma.com
中文版
Menu
Home
Products
Inhibitors
AKT Inhibitors
ALK Inhibitor
ATM Inhibitor
Aurora Kinase Inhibitors
Bcl-2 Protein Family Inhibitors
B-Raf inhibitors
CDK inhibitors
c-Met Inhibitors
EGFR inhibitor
HDAC Inhibitors
Hedgehog inhibitor
HIV Inhibitor
JAK inhibitor
MEK inhibitor
mTOR Inhibitor
PARP inhibitor
PI3K Inhibitor
PKC Inhibitor
PLK1 Inhibitor
Other inhibitors
Activator
Agonist
antagonist
API
Aurora
Metabolic Disease
VEGFR-PDGFR
Other Intermediate
Others
MOF Chemicals
About Us
Custom Synthesis
Order & Payment
Contact Us
BN-2629
Home
/
Products
/
BN-2629
BN-2629
Cat.No.
ABP018836
Chemical Name
BN-2629
CAS
232931-57-6
MDL:
MFCD19443671
MolFormula
C31H32N4O6
MolWeight
556.61
Purity
NLT 98%
Product Detail
Intermediates
Related Products
Chemical Name
: BN-2629
CAS
: 232931-57-6
BN-2629 is a DNA-intercalating agent potentially for the treatment of ovarian cancer and leukemia.
Enquiry
Name/Company
Email
Subject
Message
Enquiry ABP018836 | BN-2629 | 232931-57-6
Captcha
Copyright © 2015-2025 Active Biopharma Corp. All rights reserved. Support by
Moldb
.
浙ICP备11021315号-3
浙公网安备 33010802003999号
Scroll